Reinbek, Germany

Fritjof Evers

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Fritjof Evers: Innovator in Topical Pharmaceutical Compositions

Introduction

Fritjof Evers is a notable inventor based in Reinbek, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of topical compositions for skin disorders. His innovative work has led to the creation of formulations that are both effective and user-friendly.

Latest Patents

Evers holds a patent for "Topical pharmaceutical compositions." This patent describes compositions that include 0.01 to 0.2 wt. % of mometasone furoate, 5 to 18 wt. % of hexylene glycol, 20 to 40 wt. % of water, and 25 to 70 wt. % of an oil phase. These compositions are designed to be stable and can be safely applied over large surface areas of the skin. They are intended for the treatment or prevention of psoriasis, atopic dermatitis, and other skin disorders. Evers has 1 patent to his name.

Career Highlights

Throughout his career, Evers has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Almirall, S.A. and Almirall Hermal GmbH. His work in these organizations has contributed to advancements in dermatological treatments.

Collaborations

Evers has collaborated with several professionals in his field, including Henning Mallwitz and Ricarda Wessel. These partnerships have enhanced the development and application of his innovative pharmaceutical compositions.

Conclusion

Fritjof Evers is a distinguished inventor whose work in topical pharmaceutical compositions has made a significant impact on the treatment of skin disorders. His contributions continue to influence the pharmaceutical industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…